Reimbursed with a limitationGenericATC B01AF01

Rivaroxaban vascular Spirig HC

Rivaroxaban vascular Spirig HC is a generic from Spirig HealthCare AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 45.60 to CHF 118.55 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Spirig HealthCare AG
ATC code
B01AF01
IT group
06.03.40 Faktor-Xa-Inhibitoren
Active substances
Rivaroxabanum
Preparation type
Generic
On the SL since
01/08/2024
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Rivaroxaban vascular Spirig HC Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 2.5 mgBlist 56 StkCHF 26.83CHF 45.6001/08/2024B7680685510013
Filmtabl 2.5 mgBlist 196 StkCHF 93.92CHF 118.5501/08/2024B7680685510020

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/08/2024

In Kombination mit Acetylsalicylsäure (ASS) zur Sekundärprävention (nach Ereignis) schwerwiegender atherothrombotischer Ereignisse (Schlaganfall, Myokardinfarkt, kardiovaskulär bedingter Tod) bei Patienten mit chronischer koronarer Herzkrankheit oder manifester peripherer arterieller Gefässerkrankung und einem hohen Risiko für ischämische Ereignisse.
Im Fall von chronischer koronarer Herzkrankheit und Alter • Dokumentierte Atherosklerose unter Beteiligung von mindestens zwei Gefässbetten oder
• mindestens zwei zusätzlichen kardiovaskulären Risikofaktoren wie
  - Diabetes mellitus,
  - Niereninsuffizienz (   - Herzinsuffizienz
  - Nicht-lakunärer ischämischer Schlaganfall ≥1 Monat
  - Rauchen
Die erweiterte Behandlung mit RIVAROXABAN VASCULAR SPIRIG HC über 2 Jahre hinaus bedarf einer erneuten Evaluierung des Nutzen-Risiko-Profils des Patienten.

More preparations in this group

FAQ

Is Rivaroxaban vascular Spirig HC covered by Swiss health insurance?

Yes, but only under conditions. Rivaroxaban vascular Spirig HC is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Rivaroxaban vascular Spirig HC cost in Switzerland?

The public price is the maximum price set by the FOPH and for Rivaroxaban vascular Spirig HC ranges from CHF 45.60 to CHF 118.55 per pack. The ex-factory price ranges from CHF 26.83 to CHF 93.92. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com